Krüppel-like factor 15 ameliorates alcohol-induced liver injury in mice via regulation of the PFKFB3/AKT axis

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Acta Pharmacologica Sinica

• Publication date

  2025-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41401-025-01651-2PMID 40935894PMCID PMC12811621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meteorin-like alleviates hepatic steatosis by regulating hepatic triglyceride secretion and fatty acid oxidation.

  2025cited by this paper
• Application of lipopolysaccharide in establishing inflammatory models.

  2024cited by this paper
• KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury

  2024cited by this paper
• KLF15 alleviates oxidative stress and apoptosis of H/R-induced trophoblast cells to improve invasion and migration capacity via the activation of IGF1R.

  2024cited by this paper
• GR‐KLF15 pathway controls hepatic lipogenesis during fasting

  2023cited by this paper
• Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma

  2023cited by this paper
• Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming

  2023cited by this paper
• Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1.

  2023cited by this paper
• Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2

  2023cited by this paper
• GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota.

  2023cited by this paper
• Diallyl Trisulfide Prevents Adipogenesis and Lipogenesis by Regulating the Transcriptional Activation Function of KLF15 on PPARγ to Ameliorate Obesity.

  2022cited by this paper
• PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation

  2022cited by this paper
• Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation

  2022cited by this paper
• Kruppel-like factor 15 induces the development of mature hepatocyte-like cells from hepatoblasts

  2021cited by this paper
• PA and OA induce abnormal glucose metabolism by inhibiting KLF15 in adipocytes

  2021cited by this paper
• Neutrophils in liver diseases: pathogenesis and therapeutic targets

  2020cited by this paper
• ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development.

  2020cited by this paper
• CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.

  2020cited by this paper
• Teneligliptin promotes bile acid synthesis and attenuates Lipid Accumulation in Obese Mice by targeting the KLF15-Fgf15 pathway.

  2020cited by this paper
• Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis

  2019cited by this paper
• Alcohol, liver disease and the gut microbiota

  2019cited by this paper
• Targeting MAPKs, NF‐κB, and PI3K/AKT pathways by methyl palmitate ameliorates ethanol‐induced gastric mucosal injury in rats

  2019cited by this paper
• KLF15‐activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF‐κB‐FGF21 or SREBP1c‐FGF21 pathway

  2019cited by this paper
• β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Pathway in Alcoholic Liver Disease

  2018cited by this paper
• PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT

  2018cited by this paper
• Alcoholic liver disease

  2018cited by this paper
• Alcoholic liver disease

  2018cited by this paper
• Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations

  2018cited by this paper
• Targeting hepatic macrophages to treat liver diseases.

  2017cited by this paper
• Krüppel-like factor 15: Regulator of BCAA metabolism and circadian protein rhythmicity.

  2017cited by this paper
• KLF15 and PPARα Cooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation

  2015cited by this paper
• KLF15 Is a Molecular Link between Endoplasmic Reticulum Stress and Insulin Resistance

  2013cited by this paper
• Mouse model of chronic and binge ethanol feeding (the NIAAA model)

  2013cited by this paper
• Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15.

  2011cited by this paper
• Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.

  2011cited by this paper
• Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.

  2009cited by this paper
• Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice

  2009cited by this paper
• Publisher's Note

  2003cited by this paper
• Insulin signalling and the regulation of glucose and lipid metabolism

  2001cited by this paper

• Glutathione S-transferase Mu 3 Mitigates alcohol-induced hepatic lipid dysregulation via PYGM suppression.

  2026cites this paper